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1. INTRODUCTION 
Diabetes mellitus comprises of a group of common metabolic 
disorders that share the phenotype of hyperglycemia. It is the most 
common endocrine metabolic disorder affecting both children and adults. 
The worldwide prevalence of type 1 and type 2 diabetes mellitus is 
increasing worldwide, with especially type 2 diabetes mellitus rising 
more rapidly both in children and adults due to the recent epidemic of 
obesity and also due to lifestyle changes. In 2000, the prevalence of 
diabetes mellitus was estimated to be 0.19% in people <20 years and 
8.6% in people >20 years1. 
Type 1 diabetes mellitus, the most common form of diabetes 
mellitus encountered in childhood, accounts for approximately two thirds 
of all cases of diabetes mellitus in children2. Incidence of the disease 
varies from as high as 50 per 100,000 population in European countries 
like Finland to as low as 0.1 per 100,000 population in Asian countries 
like India2. The incidence of the disease is increasing especially in 
countries with a previous low incidence of autoimmune diseases3. It is 
predicted that the overall incidence of type 1 diabetes will be 40% higher 
in 2010 than in 19973. 
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Magnitude of the Problem in India: 
Though this disease has a low incidence in our country of only  
0.1 per 100,000 populations the magnitude of the problem is indeed huge 
considering the chronicity of the illness, its effect on growth and 
development and long-term complications on the various organ systems 
causing considerable morbidity and mortality. The disease also brings 
about with it a change in lifestyle for the young diabetics with the need 
for daily exogenous insulin therapy, blood glucose monitoring and dietary 
changes. Due to the same reasons, diabetes mellitus imposes a great drain 
on the economy. 
In India, Government health expenditure accounts for just 2% of 
the total budget and 0.8% of the Gross Domestic Product (GDP)  
(World bank Development indicators). The per capita expenditure on 
health care is only 6.4% of the average global figure, while India 
accounts for 23.5% of the world’s disability- adjusted life years lost due 
to diabetes4. Given the very limited resources available, the main thrust of 
health care provision is on the eradication of communicable diseases. 
There are also services provided by private medical practitioners for those 
who can afford the cost. 
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Shobana et al5 studied the direct cost of diabetes in patients 
attending secondary care facilities in Chennai, in the private sector.  
The median direct cost for patients receiving diabetes care in the 
private sector was US$107. They have reported that median direct cost to 
the family of an individual with type 1 diabetes is US$310 (range US$45-
1936). The percentages of family income spent on diabetes care were 
59%, 32%, 18% and 12% in low, middle, upper-middle and upper socio 
economic groups, respectively. Thus, the disease has its effects not only 
on the growth, development and emotional aspects of a child; it also 
carries the risk of long term complications with its associated morbidity 
and mortality with a significant effect on the economy as well. 
ICH experience: 
The Diabetic clinic at the Institute of Child Health and Hospital for 
Children was started in the year 1999 and has about 300 registered 
patients. The services provided at the clinic include: 
a) Monitoring of blood glucose and insulin therapy 
b) Monitoring of glycemic control 
c) Growth monitoring  
d) Monitoring for complications: 
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• Injection site assessment for atrophy/hypertrophy/abscess 
• Annual ophthalmologic review 
• Periodic monitoring of urine miciroalbuminuria for risk 
of diabetic nephropathy. 
• Blood pressure monitoring. 
• Evaluation of hands, feet and peripheral pulses for signs 
of neuropathy or peripheral vascular disease. 
• Evaluating for associated autoimmune disorder like 
thyroiditis in suspected cases. 
Hearing loss is more common in diabetic children than non-
diabetic children9. Hearing loss starts earlier in diabetic children than 
other chronic complications of diabetes21. During the onset, with mild 
degrees of hearing loss, it won’t cause much clinically recognizable 
impairment in children. Once if it is missed to be screened earlier, it will 
progress to higher degrees of hearing loss causing significant morbidity in 
children. 
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Literature did not provide much data on the incidence, type and 
degree of hearing loss, hearing loss at various frequencies. Limited 
studies only available in Indian literature to enlighten this problem21. So 
this study was conceived to look in to the association between hearing 
loss and type 1diabetes in children.  
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Immunopathology 
of Hearing Loss 
in Diabetes 
Mellitus 
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2. IMMUNOPATHOLOGY OF HEARING  
LOSS IN DIABETES MELLITUS 
Diabetes Mellitus is a common chronic metabolic disorder affecting 
both children and adults. It is characterized by chronic hyperglycemia with 
disturbances of carbohydrate, protein and fat metabolism resulting from 
defects in insulin action or insulin secretion or both. It can have long-term 
effects on the various organs of the body like the eye, kidneys, heart, 
peripheral vessels and nerves. 
The disease was first mentioned in the Eber’s papyrus as early as 
1500 B.C. The discovery of insulin by Banting et al was a significant 
breakthrough in the history of diabetes. They were followed by many 
such researchers, who have helped us to understand this disease better. 
And hence there has been a shift of terms from the older ‘Non insulin 
dependent diabetes mellitus’ and Insulin dependent mellitus’ to the newer 
‘type 1 diabetes mellitus’ and ‘type 2 diabetes mellitus’. 
Type 1 Diabetes Mellitus: 
Type 1 Diabetes Mellitus is a T cell mediated autoimmune disease 
involving β cell damage form inflammatory cytokines and auto-aggressive 
T-lymphocytes. In Type 1 DM, there is absolute insulin deficiency leading on 
to symptomatic hyperglycemia and immediate need for exogenous insulin 
replacement. 
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Epidemiology: 
Type 1 diabetes mellitus, the most common form of diabetes 
mellitus encountered in childhood, accounts for approximately two thirds 
of all cases of diabetes mellitus in children2. 
The incidence and prevalence of Type 1 DM varies dramatically 
around the world, with more than 400 fold variation in the incidence in 
reporting countries2. Type 1 DM is uncommon in India, China with an 
incidence of only 0.1/100, 0002. It is more common in Finland & Sardinia 
with an incidence of 510 cases per 100,000 populations per year2. The 
incidence of Type 1 DM is increasing throughout the world especially in 
nations with a previous low incidence of autoimmune diabetes. It is predicted 
that the overall incidence of Type 1 DM will be 40% higher in 2010 than in 
19973. Also the disease has a younger age of onset now than earlier3. 
Complications of Diabetes Mellitus: 
Diabetes Mellitus is a chronic metabolic disorder characterized by 
both acute and chronic complications. 
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Acute complications of Diabetes Mellitus: 
These include DKA, hyperglycemia and hypoglycemia, which 
occur due to the imbalance between insulin therapy and dietary intake or 
exercise. These are often encountered in Type 1 DM. 
Diabetic Ketoacidosis: 
It is an important complication of childhood diabetes mellitus and 
the most frequent diabetes related cause of death in children. It is a 
syndrome characterized by hyperglycemia, ketosis and acidemia. 
Diabetic Ketoacidosis (DKA) in diabetes mellitus can be the initial 
presentation, an acute metabolic compensation or the cause of mortality. 
In established diabetics, it can be precipitated by infections, intercurrent 
illness or by omission of insulin. 
Chronic complications of Diabetes Mellitus: 
These include retinopathy, cataracts, hypertension, nephropathy, 
neuropathy, coronary artery disease, peripheral vascular disease etc., 
These occur due to the effects of hyperglycemia or insulinopenia on the 
various  tissues and can be prevented by proper glycemic control as was 
established by the Diabetes Control and Complications Trial (DCCT)6. 
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Hearing loss is an important complication of diabetes. Initially it 
doesn’t produce self recognizable hearing impairment by the children or 
by the parents. It can manifest initially as poor school performance in 
children to speech and learning disturbances later. So it can progress to 
significant morbidity, unless it is screened earlier in mild degree by 
audiometry.  
Hearing loss and Diabetes Mellitus: 
It has been a time honored concept that incidence of hearing loss is 
higher in persons with diabetes25.  
Hearing loss occurs by three possible pathophysiological Mechanisms                        
1.  Diabetic Microangiopathy of Cochlea 
2.  Diabetic Neuropathy of Cochlear nerve 
3.  Combination of above  
I.  Diabetic Microangiopathy of Cochlea: 
(i)  Thickness of walls of capillaries in striavascularis: 
Major immuno pathology in diabetic Microangiopathy is 
increasing in thickness of capillary wall in striavascularis. 
Hisakifuskushema et al8 studied in 1985 with temporal bones of 13 
diabetic patients with type 1 DM and showed that the mean thickness of 
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capillary walls under basilar membrane  in all turns of cochlea combined 
,in diabetics (2.27μm+SD 0.60) was significantly higher than that of 
controls (1.60 μm + SD 0.32). 
 
Figure 1-a.  There is thickening of the capillary walls in the 
stria vascularis in lower middle turn of the cochlea 
from a 39-year old female with a 33-year-history 
of type 1 diabetes  mellitus.HE, x200. 
Figure 1-b.  There is total occlusion of a capillary (arrow head) 
and complete loss of stria vascularis in lower 
middle turn of the cochlea from a 38-year old 
female with a 19-year-history of type 1 diabetes 
mellitus. HE, x200. 
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(ii)  Loss of outer hair cells: 
Loss of outer hair cells in basal turn of cochlea is another proposed 
pathological changes in cochlea causing hearing loss in diabetes. 
Wackym-pa et al9 studied temporal bones of 68 type 1 diabetic patients 
and found that significant loss of outer hair cells in diabetics ( 24.3%+SD 
16.6) compared with controls (15.4%+SD 4.1) in the lower basal turn.  
Finally he concluded that there was a correlation between loss of outer 
hair cells in lower basal turn and increased thickness of capillary wall in 
basilar membrane in diabetics. 
(iii)  Atrophy of Striavascularis: 
Atrophy of Striavascularis is another important histopathological 
change in microangipathy of cochlea causing hearing loss in diabetes. 
Makishima K, etal10 conducted a study in 1996 and showed that total area 
of all five turns of Striavascularis in diabetics (19808 μm2+ SD 6910) 
was significantly lower than controls ( 32113 μm2+ SD 4302) . He also 
correlated the thickness of capillary wall in basilar membrane and atrophy 
of Striavascularis. 
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(iv)  Loss of Spiral Ganglion cells: 
Loss of Spiral Ganglion cells in cochlea can cause hearing loss, and 
it was proved by Costa OA et al11 in 1993. From his study, he observed 
that there is significant loss in number of spiral Ganglion cells in any 
segment of cochlea between Diabetics and controls. 
II)  Diabetic Neuropathy of Cochlear Nerve: 
This is another pathophysiology of hearing loss in diabetes next to 
diabetic microangiopathy. 
Like other Neuropathy occurring in diabetes, auditory Neuropathy 
can cause hearing loss12. Friedman et al showed in his study that his 
diabetic patients with peripheral neuropathy had high threshold of hearing 
secondary to auditory neuropathy.   
Doyle KJ et al24 concluded from his study with 58 diabetic 
children, that auditory neuropathy caused prolonged inter wave latencies 
in BERA. He also positively correlated the high threshold of hearing for 
his study population with auditory neuropathy. 
Even though both diabetic microangiopathy and cochlear 
neuropathy can cause hearing loss, most studies21,26 favors 
microangiopathy theory as a major pathophysiology of hearing loss. 
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Literature Review
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LITERATURE REVIEW 
Apart from the well described association between congenital 
deafness and the maternally inherited type of diabetes mellitus in the 
wolfram syndrome13, the relationship between type 1 DM and hearing 
impairment has been a subject of debate since Jordao et al14 reported a 
case of hearing loss with incipient diabetic coma almost 150 years ago. 
Incidence of hearing loss in diabetes: 
Kakal Paudi et al15 on May 2003 conducted a retrospective data 
base review from 1989 to 2003, concluded that sensorineural hearing loss 
was more common in patients with diabetes than in the control 
nondiabetic patients. He also observed that the severity of hearing loss 
seemed to correlate with progress of disease as reflected in Sr. Creatinine 
and glycosylated Hb level (HbA1c). This may have been due to 
microangiopathic disease in inner ear. 
Incidence of hearing loss in various studies 
Limited studies are available in literature to show the actual 
incidence of hearing loss in diabetes. Most of studies quoted that 
incidence of hearing loss in type1 diabetes ranging from 25 to 35%. 
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Incidence of hearing loss 
Authors  Incidence of hearing loss 
Elamin et al20 30% 
Virtaniemi J et al24 32% 
TayHL et al30 36% 
De espana et al34 28% 
DCCT17 26% 
Lisowska et al16 24% 
Kurion M et al14 29% 
Celik O et al28 32% 
Pathogenesis of hearing loss in diabetes: 
i) Microangiopathy and hearing loss  
Hearing loss occur in diabetes secondary to diabetic 
microangiopathy and auditory neuropathy as evidenced by the study of 
Hisakifuskushema et al8. He studied with temporal bones of 13 type 1 
diabetic children and concluded that hearing loss in diabetes is due to 
diabetic microangiopathy. 
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ii) Auditory neuropathy and hearing loss                                                                       
Auditory Neuropathy can cause hearing loss. It is evidenced by the 
study of Durmus C etal16.He Showed that absolute latencies of waves I, 
III, V, and Interwave latencies between III & V by Brainstem evoked 
auditory response were significantly higher in diabetics compared to 
controls. He concluded that prolongation of latencies of ABER in patients 
with DM is due to damage of cochlear nerve. 
Hearing loss and age of diabetic patients: 
Hearing loss occurs in diabetics more frequently as age advances. 
In adults, diabetes influences age related hypoacuosis, evidenced by the 
study of Ferrer et al17 on 1991 with 46 diabetic patients using pure tone 
audiometry. He observed that the threshold of hearing in all frequencies 
was quiet higher and it was associated with age, duration of disease as 
well as retinopathy. He concluded that age related hypoacuosis, is 
influenced by diabetes. 
Hearing loss and diabetic age: 
Hearing loss occurs more frequently as diabetic age advances.  
Tay et al18 shows in his study of 102 type 1 diabetic children, that the 
threshold of hearing was higher in low and mid frequencies and it was 
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positively  correlated with diabetic age. He observed that the diabetic age 
advances by more than 5 years, there is higher incidence of hearing loss. 
Hearing loss in various frequencies: 
Hearing loss in diabetes occurs commonly in mid and high 
frequencies as the basal turn of cochlea is more affected. De epsana et al19 
conducted a study in Barcelona university spain with two groups  
(Group I: early diabetics, group II: chronic diabetics). In group 1 (17/47) 
patients developed hearing loss at high and mid frequency, in group II 
(30/47) patients developed hearing loss at all frequencies. He concluded 
that a diabetes initially affects basal turn of cochlea as evidenced by mid 
and high frequency hearing loss in early diabetics. As diabetic age 
advances with involvement of apical turn of cochlea, there will be hearing 
loss at all frequencies in chronic diabetics. 
Hearing loss and Metabolic Control: 
Hearing loss in diabetes significantly correlated with degree of 
metabolic control (Glycosylated Hb). 
Elamin et al20 conducted a study in 2005 with 63 sudansi diabetic 
children below the age of 18 years and concluded, that hearing loss 
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occurs earlier in diabetic children and is related to duration of diabetes 
and the degree of metabolic control.  
Hearing loss and acute complications: 
Hearing loss in diabetes is a chronic complication.  Celik et al21, 
elamin et al20, studied with 75 patients with IDDM and observed that 
hearing loss positively correlated with chronic complications like 
retinopathy and nephropathy, not with acute complications like 
Hypoglycemia and DKA.  
Hearing loss and retinopathy, nephropathy: 
Microangiopathic complications like nephropathy and retinopathy 
are correlated with hearing loss. Ferrer et al22 and Elemin et al20 
performed a study with 98 diabetic children in 1991.  They observed that 
hearing loss was positively correlated with background and proliferative 
diabetic retinopathy and nephropathy, because all of this three 
complications are different spectrum of diabetic microangiopathy. 
Peripheral neuropathy and hearing loss: 
Cochlear neuropthy is another important cause of hearing loss in 
diabetes. Cochler neuropathy in diabetes is either due to direct inositol 
induced injury by chronic hyperglycemia or by microangipathy of 
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vasanervosa of cochlear nerve was not clearly known. Celik O et al22 and 
Huyang et al23 observed from their studies that cochlear neuropathy 
identified by BERA causing hearing loss was positively correlated with 
peripheral neuropathy identified by Nerve conduction studies (NCS).  
Thyroid dysfunction and hearing loss: 
Significant numbers of studies are available in literature to show 
the auto immune dysfunctions in diabetes including auto immune 
thyroiditis, celiac disease, addisions disease and multiple sclerosis.  
Mjmekenna et al21 screened 371 diabetic children for thyroid 
microsmal antibodies and noticed that 7% of children had thyroid 
dysfunction. So he recommended that all the diabetic children should be 
screened for thyroid dysfunction shortly after diagnosis of IDDM. 
None of the study positively correlated the hearing loss and thyroid 
dysfunction in diabetes13, probably because hearing loss in diabetes is due 
to microangiopathy and not secondary to auto immune problem. 
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Justification
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STUDY JUSTIFICATION 
Hearing loss is more common in diabetic children and also occurs 
much earlier than expected13. Though Hearing loss in adult diabetes have 
been extensively studied22, literature does not provide much data on 
hearing loss in childhood diabetics17 especially in India as research data 
on diabetes in children is scarce. 
Most of western literature20-24 shows that hearing loss occurs earlier 
in diabetic children and positively correlates with poor glycemic control. 
By early detection of hearing loss in diabetic children and maintaining 
them on strict glycemic control, we can prevent the occurrence and 
progression of hearing loss14. Hence there is an urgent need to study the 
actual incidence of hearing loss in diabetic children and  when to screen 
the diabetic children for hearing loss, also how hearing loss is correlating 
with metabolic control and the acute and chronic complications of 
diabetes.  
So this study is expected to be very helpful in identifying the 
presence of hearing loss in diabetic children, in order to prevent its 
occurrence.  
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OBJECTIVES OF THE STUDY 
i. To examine the auditory function in a group of children 
more than 5 years of age with type 1 diabetes mellitus. 
2. To know the incidence of hearing loss in diabetic and non 
diabetic children. 
3. To assess the degree of hearing loss and its distribution in 
various frequencies. 
4. To analyze the various risk factors like metabolic control and 
complications of diabetes for hearing loss. 
5. To compare the threshold of hearing in diabetic children    
without hearing loss and non diabetic children. 
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Methods
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MATERIALS AND METHODS 
The study was conducted at Institute of Child Health and Hospital 
for Children, Madras Medical College, a Tertiary care Children’s 
Hospital in Chennai during the period between Nov 2005 and Aug 2007. 
It was carried out with case control study design. 
Study population was classified in to two groups. Children with 
diabetes attending the diabetic clinic at the Institute of Child Health and 
Hospital for children (Group I) were enrolled as cases. An equal number 
of age and sex matched Children without diabetes mellitus from school 
health cell and near by Govt. Higher Sec. School during school visit 
conducted by School Health Cell were enrolled as comparison group 
(Group II). 
Diabetic and non diabetic children were selected with following 
inclusion and exclusion criteria for study enrollment. 
Inclusion Criteria:  
For Group I - Children of age  more than 5 years with diabetes 
mellitus  attending diabetic clinic and on regular follow up and willing to 
participate in the study.  
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For Group II: Age and Sex matched children free of diabetes 
mellitus and willing to participate in the study. 
Exclusion Criteria:  
• Children with CSOM 
• H/O Head or ear trauma 
• Family H/O Congenital deafness 
• Features of Wolfram syndrome 
• Known Ototoxic drug exposure 
Sample Size: 
From the previous studies it was found that the incidence of 
hearing loss in diabetic children was about 30%21-23. Among normal 
children, the incidence of Sensorineural Hearing Loss is almost 0.1% 14, 19 
(1 in 1000). With an α error of 5% and a power of 90%, the sample size 
is calculated to be 31 in each group. 
Since in the diabetic clinic about 300 children are registered, it was 
considered to perform the study with twice the number of calculated 
study sample. 
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So the study was conducted with 62 diabetic children (Twice the 
number of calculated sample) and 62 age and sex matched non diabetic 
children 
Manoeuvre: 
The study was conducted at the Institute of Child Health and 
Hospital for Children between the period of November 2005 to August 
2007. The cases were enrolled for the study from the diabetic clinic at the 
institute. 
Though 300 diabetic children are registered, those children aged 
more than 5 years were only enrolled in this study. As it is essential to 
understand and perform the exercises of pure tone audiometry, those 
children aged more than 5 years who are capable of understanding and 
reciprocating the tasks involved in audiometry were selected and 
enrolled. 
Out of the 300 children registered in our diabetic clinic, only 142 
children were on regular follow up. Of these 142 children, 128 were more 
than 5 years of age. 62 children were selected randomly from this group 
and were enrolled into the study. 
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All patients are treated with human insulin provided by our 
diabetic clinic. Blood glucose was estimated every time when the child 
was attending the diabetic clinic.  
Their glycemic control was assessed by measuring glycosylated Hb 
once in 3 months. Children were subjected to undergo hearing assessment 
once in every three months while taking blood for glycosylated Hb 
measurement. 
Before doing hearing assessment, age at onset of Diabetic Mellitus 
was noted to calculate the exact diabetic age of the children. Previous 
history of hearing impairment, ear discharge, head or ear trauma and 
family history of congenital deafness were enquired. Other associated 
acute complications like hypoglycemia, diabetic ketoacidosis and chronic 
complications like nephropathy, retinopathy were assessed.  
Hypoglycemia was considered only when it required assistance 
from the parents or by hospital. Diabetic ketoacidosis was considered 
only when confirmed and treated in hospital. Retinopathy was assessed 
by periodic retinal examination. Nephropathy was assessed by albumin 
excretion rate and by estimation of blood urea, serum creatinine and 
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electrolytes. Then clinical assessment of hearing was done in all children 
by doing Rinnes test, Webers test, ABC conduction test. 
Those who were able to understand and reciprocate the above 
clinical tests were subjected to undergo otoscopic examination and 
Puretone audiometry using Amplaid 300 clinical audiometer. None of the 
study population had any ear pain or hearing loss following an exposure 
of excessive noise or sound. 
Following a thorough ENT examination, pure tone audiometry was 
performed in a sound proof room for both cases and controls. Both air 
and bone conductions were tested at low, mid and high frequencies. 
Out of 62 diabetic children, 13 children had hearing loss during the 
study period. Those 13 children were subjected to hearing assessment for 
at least more than twice during the study period. Controls were also 
subjected to hearing assessment by puretone audiometry. As none of 
them had hearing loss in the initial visit, they were not followed up. 
Definition of Hearing Loss: 
Any children with average threshold of hearing more than 25 db in 
any frequency by pure tone audiometry were considered to have hearing 
loss. 
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Audiometry was done in 3 different frequencies. 
1.  Low frequency (250 to 1000 Hz) 
2.  Mid frequency (1000 to 4000 Hz) 
3.  High frequency (4000 to 8000 Hz) 
Degree of hearing impairment were analyzed according to WHO  
classification. 
DEGREE OF HEARING LOSS 
1. Mild :-  26 to 40 db 
2. Moderate :-  41 to 55 db 
3. Moderately severe :-  56 to 70 db 
4. Severe :-  71 to 91 db 
5. Profound :-  >91 db  
All the diabetic children completed the one year follow up period. 
There were no deaths in either group. The results are discussed 
subsequently. 
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RESULTS 
  A total of 62 diabetic children were enrolled in the study and same 
number of age and sex matched non-diabetic children were identified 
with same exclusion criteria from school health cell of ICH&HC and 
from nearby government higher secondary school during school visit by 
school health cell of ICH&HC Chennai were enrolled as a comparison group.  
Diabetic children who were diagnosed to have hearing loss at the 
beginning of the study were followed for 2 years and hearing was 
assessed once in 3 months, when they were assessed for glycemic control 
by estimating Glycosylated Hemoglobin. The data was analyzed using 
SPSS software version 11.0 for windows.  
The results were analyzed as follows:- 
1. Presence of hearing loss in diabetic and non diabetic children. 
2. Profile of hearing loss  
3. Risk factor for hearing loss 
4. Co morbidities of diabetes and hearing loss 
5. Hearing loss in various frequencies with metabolic control. 
6. Threshold of hearing in diabetic and non diabetic children. 
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1. PRESENCE OF HEARING LOSS IN DIABETIC  
AND NONDIABETIC CHILDREN 
Comparing to non diabetic children hearing loss is more common 
in diabetic children. 
Hearing Loss 
Present 
Hearing Loss 
Absent Study Population 
n % n % 
Diabetic Children 13 20.9 49 79.1 
Non diabetic Children 0 - 62 100.0 
χ2 value = 14.5 (p-value = 0.00) 
*(chi square test)  
 
In this study 13 (20.9%) diabetic children had hearing loss. None of 
the non diabetic children had hearing loss. 
Analysis shows that there is significant difference in incidence of 
hearing loss between diabetic children and non diabetic children.  
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2.  PROFILE OF HEARING LOSS IN DIABETIC CHILDREN 
a)  Sensory Neural Hearing Loss in Various Frequencies  
In pure tone audiometry hearing is assessed for both air and bone 
conduction between 250 to 8000 Hz and 250 to 4000 Hz respectively. On 
the air conduction, tested between 250 to 8000 Hz, hearing is assessed in 
3 different ranges of frequencies. 
1. Low frequency (250 to 1000 Hz) 
2. Mid frequency (1000 to 4000 Hz) 
3. High frequency (4000 to 8000 Hz) 
Sensory Neural Hearing Loss in Various Frequencies 
Sensory Neural Hearing Loss 
Sex All frequencies  
(low, mid and high) Mid and high frequencies 
Total 
Male 2  4  6 
Female 2  5  7 
Total 4 (30.7%) 9 (69.2%) 13 (100%)
Out of 13 diabetic children with hearing loss, 4 children (30.7%) 
developed hearing loss at all frequencies, 9 (69.2%) children developed 
hearing loss at mid and high frequencies. 
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SOME PURE TONE AUDIOMETRIC GRAPHS OF THE STUDY 
DEPICITED BELOW TO REPRESENT THE DEGREE OF 
HEARING IMPAIRMENT 
NORMAL HEARING ASSESSMENT 
 
Threshold of Hearing in both ears at all frequencies is 25 db. 
Impression:  Normal hearing assessment in both ears. No hearing loss 
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SENSORY NEURAL HEARING LOSS AT MID AND  
HIGH FREQUENCIES 
 
Average threshold of hearing in right ear is 35db at mid and high 
frequencies. 
Average threshold of hearing in left ear is 20db at all frequencies. 
Inference: Mild degree of sensorineural hearing loss at mid and high 
frequencies in right ear, hearing assessment in left ear normal. 
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SENSORY NEURAL HEARING LOSS AT ALL FREQUENCIES 
 
 
 
Average threshold of hearing in right ears at all frequencies is 35db.  
Average Threshold of hearing in left ear at all frequencies is 30 db. 
Impression:   Mild degree of Sensory Neural Hearing Loss at all 
frequencies in both ears. 
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b)  Degree of Sensorineural Hearing Loss in Diabetic Children 
Degree of hearing loss (WHO classification) 
WHO recommends the following classification on the basis of pure 
tone audiometry taking the average threshold of hearing for frequencies 
500, 1000, 2000 Hz with reference to ISO: R 389-1970. 
Degree of Hearing Loss 
1. Mild    :-  26 TO 40 db 
2. Moderate   :-  41 to 55 db 
3. Moderately severe  :-  56 to 70 db 
4. Severe    :-  71 to 91 db 
5. Profound   :-  >91 db  
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c)  Degree of sensorineural hearing loss in diabetic children 
 
Sensorineural Hearing Loss 
Sex 
Mild Moderate Moderately severe Severe Profound 
Male 6 (21.42%) 0 0 0 0 
Female 7 (20.58%) 0 0 0 0 
Total 13 (20.96%) 0 0 0 0 
 
All the 13 diabetic children developed hearing loss in mild degree. 
All the 13 children of mild sensorineural hearing loss identified at 
the beginning of the study were followed up with strict glycemic control 
over 2 years of study period, neither of them progressed from mild to 
higher degrees of hearing loss, nor regressed to normal threshold of 
hearing (<= 25 db) even after good glycemic control. 
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3.  RISK FACTORS FOR HEARING LOSS IN DIABETIC      
CHILDREN  
i) Gender of diabetic children.  
ii) Age of diabetic children 
iii) Diabetic Age (duration between the date of diagnosis of 
diabetes and date of first hearing assessment) 
iv) Age at onset of diabetes 
v) Glycosylated hemoglobin 
vi) Co morbidity relating to management of diabetes 
a. Diabetic ketoacidosis 
b. Hypoglycemia 
vii) Co morbidity relating to involvement of other organ systems 
in diabetes 
a. Thyroid dysfunction 
b. Nephropathy 
c. Retinopathy 
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(i)  Gender and hearing loss 
Hearing Loss p-Value Gender 
Present Absent 
Total 
Male 6(46.1%) 49(100%) 28(45.1%) 
Female 7(53.8%) 27(55.1%) 34(54.9%) 
Total 13(100%) 49(100%) 62(100%) 
0.42 
*(Chi square test) 
χ2 value 0.62 
Out of 13 diabetic children with hearing loss 6 (46%) are males and 
7 (54%) are females. 
There is no significant difference in incidence of hearing loss 
according to gender. 
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ii)  Age of diabetic child and hearing loss 
Incidence of total hearing loss were analyzed with respect to age as 
5-10 yrs, 11-15 yrs, since the children more than 5yrs of age only can 
understand and perform the exercise of pure tone audiometry. 
Hearing loss 
Present 
Hearing loss 
Absent Age 
(Yrs) 
n % n % 
Total 
n p-Value*
5 – 10        4      30.7       10       20.4       14 
11 - 15        9       69.2       39       79.5       48 
Total       13      100       49        100       62 
0.43 
*(chi square test)  
χ² value: 0.63, OR: 1.7(95% CI: 0.36, 8.13) 
Under age group between 5-10 yrs, 4(30.7%) children had hearing 
loss between 11-15 yrs, 9(69.2%) children had hearing loss 
Analysis of chi-square test, showed there is no significant 
association between age and hearing loss, since p-value is > 0.05 
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iii)  Diabetic age and hearing loss  
Incidence of hearing loss in diabetic children were analyzed with 
respect to diabetic age less than 5 yrs and between 5-10 yrs,  
Since diabetic age in the study population ranging from 1 yr to maximum 
of 8 yrs. 
Hearing loss 
Present 
Hearing loss 
Absent 
p-
Value* Diabetic Age 
n % N % 
Total   
n 
< 5 yrs 9 69.2 45 91.8 54 
5-10 yrs  4 30.7 4 8.1 8 
Total  13 100 49 100 62 
0.03 
*(chi square test),      χ² value: 4.7, OR : 5.0(95% CI : 0.8, 30.9) 
Among 13 diabetic children with hearing loss, 4(30.7%) children 
were between diabetic age of 5-10 yrs, 9(69.2%) were diabetic age <5 yrs. 
Analyses of chi-square test showed that there is a significant 
association between diabetic age and hearing loss. Since odds ratio 
calculated was 5, children between 5-10 yrs of diabetic age had 5 times 
more risk of developing hearing loss as compared to children <5 yrs of 
diabetic age. 
This shows that as diabetic age increases more than 5 yrs, there 
will be an increase in incidence of hearing loss. 
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iv)  Age at onset of diabetes and hearing loss 
Incidence of hearing loss in diabetic children were analyzed with 
respect to the age at onset of diabetes between less than 5yrs and 6-10yrs, 
since all the diabetic children under study had age at onset of diabetes 
less than 10yrs. 
Hearing loss 
Present 
Hearing loss 
absent Age at on set of 
diabetes n % n % 
Total p-value*
<5yrs 7 53.8 34 69.38 41 
6-10yrs 6 46.1 15 30.6 21 
Total 13 100 49 100 62 
0.3 
*(chi square test)  
χ² value: 1.1, OR : 1.9(95% CI : 0.5, 8.0) 
Among 13 diabetic children, 7 (53.8%) had age at onset of diabetes 
less than 5 yrs and 6 (46.1%) had age at onset of diabetes between 6-10 yrs. 
Analysis of chi-square test shows that there is no significant 
association   between age at onset of diabetes and hearing loss, since p-
value is > 0.05. 
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v)  Glycosylated Hb and hearing loss  
Metabolic control of diabetes was assessed by estimating 
glycosylated Hb once in 3 months. Incidence of hearing loss in diabetic 
children were analyzed with respect to Glycosylated Hb (HbA1c) 
between < 7 and >7, since the goal of mean HbA1c as per PCNA 
(Pediatric clinics of North America) guidelines for age group between 5-
10 yrs is <7.5 and <7 for children aged more than 10 years to get strict 
glycemic control.     
Hearing Loss 
HbA1c 
Present Absent 
Total p-Value* 
>7 13 35 48 
<7 0 14 14 
Total 13 49 62 
0.03 
*(chi square test),   χ² value: 4.8 
All 13 diabetic children had HbA1c level >7. 
Analysis of chi-square test showed that there is a significant 
association between hearing loss and Glycosylated Hb, since p-value is 
<0.05. It shows that hearing loss occurs more frequently in diabetic 
children with poor glycemic control. 
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THRESHOLD OF HEARING AND 
METABOLIC CONTROL 
 
 
Red Curve Shows Diabetic children with hearing loss (13 Children) 
Green Curve Shows Diabetic children without hearing loss (49 Children) 
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Threshold of Hearing and Metabolic Control 
As previously mentioned there is a positive correlation between 
Hearing Loss and Metabolic Control (Glycosylated Hb). 
Threshold of Hearing by Puretone audiometry more than 25 db was 
considered as hearing loss. Out of the 62 diabetic children, 49 children 
had normal threshold of hearing (No hearing loss), and 13 diabetic 
children had hearing loss. 
As per PCNA guidelines, the ideal goal of mean glycosylated Hb is 
less than 7 % to get good glycemic control.     
Out of 49 children without hearing loss, 39 children had 
Glycosylated Hb value less than 7% and remaining 10 children had value 
more than 7%. These 10 children are at risk of developing hearing loss at 
any time if they are not maintained with strict glycemic control. 
All the 13 diabetic children with hearing loss had Glycosylated Hb 
value, invariably more than 10%. So the hearing loss occurs more 
frequently, when there is a poor metabolic control. 
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4.  COMORBIDITY OF DIABETES AND HEARING LOSS 
Acute and Chronic complications are considered as comorbidity of 
diabetes. Acute complications like hypoglycemia, and diabetic 
Ketoacidosis (DKA) are considered as co-morbidity relating to 
management of diabetes. Chronic complications like nephropathy, 
retinopathy and thyroid dysfunction are considered as co-morbidity in 
relation to the involvement of various organ systems. 
Comorbidity Hearing Loss Present 
Hearing Loss 
Absent 
P 
Value 
Present 13 41 Hypoglycemia 
Absent 0 8 
0.12 
Present 13 3 DKA 
Absent 0 46 
0.15 
Present 0 2 Nephropathy 
Absent 13 47 
0.5 
Present 0 28 Retinopathy 
Absent 0  34 
- 
Present 0 2 Thyroid 
Dysfunction  
Absent 13 47 
0.16 
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i)  Hearing Loss and Acute Complications:- 
All the 13 Diabetic children with hearing loss developed at least 
one episode of hypoglycemia and DKA during the study period. Analysis 
of Chi square test shows that there is no significant association between 
hearing loss and hypoglycemia and DKA as Calculated p value is > 0.05. 
ii)  Hearing Loss and Chronic Complications:- 
In the present study two diabetic children had diabetic nephropathy 
as evidenced by persistent microalbuminuria during the study period, but 
none of them developed hearing loss. 
Among 62 diabetic children of the present study, neither of them 
had retinopathy at the beginning, nor they developed during the 2 years of 
followup period. 
In this study 2 diabetic children had thyroid dysfunction but none 
of them had hearing loss. Analysis of Chi Square test shows that there is 
no significant association between thyroid dysfunction and hearing loss 
because of both of them had different pathogenesis. Thyroid dysfunction 
is due to autoimmune problem, hearing loss is due to diabetic 
microangiopathy. 
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5)  HEARING LOSS AT VARIOUS FREQUENCIES WITH        
METABOLIC CONTROL 
In this study Hearing assessment was done at three different 
frequencies using pure tone audiometry. 
• Low Frequency –   250 to 1000 Hz. 
• Mid Frequency – 1000 to 4000 Hz. 
• High Frequency – 4000 to 8000 Hz 
Hearing Loss at different frequencies was correlated with 
metabolic control (Glycosylated Hb) as shown below. 
a)  Glycosylated Hb and Hearing loss at low frequency 
Hb 
A1C 
Hearing Loss at Low 
Frequency Present 
Hearing Loss at Low 
Frequency Absent 
p 
value* 
>7% 4 44 
<7% 0 14 
    0.04 
*(Chi Square test), χ2 = 4.2 
 
 
58
In this study out of 13  diabetic children with hearing loss, 4 
children developed hearing loss at low frequency and all the 4 children 
with hearing loss at low frequency had HbA1C values >7. Analysis of chi 
square test showed that there is a significant association between hearing 
loss at low frequency and glycosylated Hb (HbA1C). 
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b)  Glycosylated Hb and Hearing Loss at Mid and High frequency 
 
Hb 
A1C 
Hearing Loss at Mid and 
High Frequency Present 
Hearing Loss at Mid and 
High Frequency Absent 
p 
value*
>7% 9 39 
<7% 0 14 
0.03 
*(Chi Square Test),  χ2 = 4.8 
In our study out of 13 diabetic with Hearing Loss, 9 children 
developed hearing loss at Mid and High frequencies and all these  
9 children with hearing loss at Mid and High frequencies had HbA1C 
values >7. Analysis of chi square test showed that there is a significant 
association between hearing loss at Mid and High frequencies and 
glycosylated Hb (HbA1C). 
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c)  Correlation between Glycosylated Hb (HbA1C) and threshold of 
hearing 
 
Threshold of Hearing Correlation (r) p-value 
Low Frequency 0.34 0.01 
Mid Frequency 0.42 0.001 
High Frequency 0.40 0.001 
 
The above table shows that there is a positive correlation between 
threshold of hearing at all frequencies with glycosylated Hb. There is a 
more positive correlation between threshold of hearing at mid and High 
frequencies than at low frequency in relation with HBA1C. 
Since diabetic microangiopathy of Cochlea affects mainly the basal 
turn of cochlea, hearing loss occurs more at mid and high frequencies 
initially. As the diabetic age advances, it will affect apical turn also 
producing hearing loss at low frequency. 
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6)  THRESHOLD OF HEARING BETWEEN NON DIABETIC 
CHILDREN AND DIABETIC CHILDREN WITHOUT 
HEARING LOSS 
Threshold of hearing is higher in diabetic children than non 
diabetic children. 
Non Diabetic 
Children 
Diabetic Children without 
Hearing Loss Threshold of 
Hearing 
Median Range Median Range 
p-
value 
Low 
Frequency 
10 5 to 20 20 10 to 25 0.00 
Mid Frequency 10 5 to 20 20 10 to 25 0.00 
High 
Frequency 
15 5 to 20 20 15 to 25 0.00 
Mann-Whitney U test 
Analysis of Mann - Whitney U test showed that the threshold of 
hearing for Diabetic children without hearing loss was higher than non 
diabetic children even though they have not developed hearing loss 
during the study period.  
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Diabetic children without hearing loss already developed evidences 
of diabetic micorangiopathy of cochlea as evidenced by high threshold of 
hearing compared to non diabetic children. 
So if the diabetic children without hearing loss, not maintained 
with good glycemic control anytime they may develop  hearing loss and 
can progress from mild degree  to higher degrees of hearing loss 
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Summary of the 
Study
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SUMMARY OF THE STUDY 
From the analysis of hearing loss in diabetic children, 13 (20%) 
diabetic children were identified to have Sensorineural hearing loss. All   
these children had mild degree of hearing impairment (26-40 db). Neither 
of them had progressed to higher degrees of hearing impairment, nor 
regressed to normal threshold of hearing on follow up for 2 years. 
Out of the 13 diabetic children with hearing loss, 2/3rd of them 
were identified to have hearing impairment at mid and high frequencies 
and less than 1/3rd had hearing impairment at low frequency.  
Associations of various risk factors and co morbidities with hearing 
loss were analysed. There is statistically significant association between 
hearing loss and diabetic age and metabolic control (Glycosylated Hb). 
There is no statistically significant association between gender, age, age 
at onset of diabetes mellitus, acute complications like hypoglycemia, 
diabetic ketoacidosis, chronic complications like nephropathy, 
retinopathy, thyroid dysfunction and hearing loss. 
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In our study only 2 diabetic children were diagnosed to have 
diabetic nephropathy. Neither of them had hearing loss at beginning, nor 
developed during the whole study period. 
In our study only 2 diabetic children were diagnosed to have 
thyroid dysfunction. Neither of them had hearing loss at beginning, nor 
developed during the whole study period. 
Hearing loss in all frequencies positively correlated with degree of 
metabolic control (HBA1c) especially in mid and high frequencies  
(1000-8000 Hz). 
Threshold of hearing in all diabetic children even without hearing 
loss were statistically higher, when compared to non diabetic children. 
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Discussion
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DISCUSSION 
Comparison with other Studies and Literature Review:- 
Most of the studies on hearing loss in DM have been done only in 
adults with either type 2 or type 1 diabetes12. There is paucity of data on 
hearing loss in diabetic children. Review of literature shows that hearing 
loss is more common in diabetics18. Hisaki fuskushima et al8 concluded 
from his study that there are three main theories are available to explain 
the pathogenesis of hearing impairment in DM8, 21, 32. 
 These are 
1.  Micro angiopathy of cochlea 
2.  Auditory Neuropathy 
3.  Combination of the above. 
Elamin et al20 favours microangipathic theory, which is supported 
by histopathological findings on temporal bones and inner ear8, 10. 
Thickening of capillary wall with secondary ischemia in the cochlea and 
the 8th cranial nerve16 have been demonstrated in diabetic patients and 
experimental animal models by Durmus et al on 198016. 
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Elamin et al20 studied 63 Sudensi diabetic children using bovine 
insulin and showed that there is 30% incidence of hearing impairment in 
diabetic children with mild, moderate and severe degrees of hearing loss. 
Since in our hospital we are using human insulin and maintaining 
the diabetic children with strict glycemic control and advising them on 
regular follow up with compliance in insulin usage and meal plan, our 
study revealed that decreased incidence of Sensorineural hearing loss in 
diabetic children as 20% when compared to 30% in other studies29. 
With the same reason mentioned above all of our study population 
developed only mild degree of hearing impairment and none of them 
progressed to higher degrees of hearing loss.  
Since micro-angiopathy of cochlea is an irreversible damage 
proved by Virtanemi et al24, all children with hearing loss in this study 
population were not regressed to normal threshold of hearing, even after 
maintenance of strict glycemic control. But we can prevent further 
progression of hearing loss by maintaining them on good glycemic 
control. 
Since diabetic micro-angiopathy mainly affecting the basal turn of 
cochlea evidenced by the study of De espanas et al11, in the present study 
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also hearing loss occurs more at mid and high frequencies. In this study 
2/3rd of diabetic children with Sensorineural hearing loss had hearing 
impairment at mid and high frequencies and the remaining 1/3rd at low 
frequency. This is evidenced in this study by statistically significant 
association between hearing loss at mid and high frequency with 
glycemic control than at low frequency.  
Elamin et al20 concluded that hearing loss is associated with degree 
of metabolic control. Present study also shows that hearing impairment 
occurs earlier in diabetic children with high HBA1C levels. Ideal HBA1c 
level is considered as a tool for good metabolic control. 
GOAL OF MEAN HBA1c % AS PER PCNA GUIDELINES: 
1. Infants and toddlers    ….  <8% 
2. Children between 5 – 10 years    ….  <7.5% 
3. Adolescent      ….  <7% 
Hearing loss occurs more frequently as diabetic age advances. 
Ferrer J.P et al17 shows in his study that when the diabetic age increases, 
the hearing loss occurs more frequently. His calculated mean diabetic age 
to develop hearing loss was 7 years, and it is 5 years for the study 
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population of Elamin et al. In the present study also the hearing loss is 
positively correlated with mean diabetic age. The observed mean diabetic 
age to develop hearing loss in the present study is 5 years. As the odds 
ratio calculated in the present study is 5, there is 5 times increase in risk 
of developing hearing loss when diabetic age increases by more than  
5 years. 
Celik et al20 studied 205 adult diabetic patients and observed that 
the hearing loss at high frequency is positively correlated with 
nephropathy and retinopathy. In pediatric age group retinopathy occurs 
by late adolescence21 and nephropathy develops at early or mid 
adolescence14. In the present study all the children studied comes under 
early adolescent period. Two of the study population had nephropathy as 
evidenced by persistent microalbuminuria but neither of them developed 
hearing loss. None of the study population developed retinopathy which 
is a chronic complication of diabetes mellitus.  
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Conclusion
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CONCLUSION 
¾ Hearing loss occurs earlier in type 1 diabetic children. 
¾ Sensorineural hearing loss in diabetic children occurs 
predominantly at mid and high frequencies. 
¾ Hearing loss is positively correlated with degree of gylcemic 
control. 
¾ There is significant association between hearing loss & diabetic age. 
¾ If diabetic age increases by more than 5 yrs, there is an increase in     
Incidence of hearing loss 
¾ It is mandatory to perform hearing assessment after 5 years from 
the onset of diabetes, at least once in 3 months when they are 
subjected to undergo glycosylated hemoglobin estimation to assess 
metabolic control.  
¾ It is necessary to perform hearing assessment even before 5 years 
of diabetic age, if the children show poor metabolic control. 
¾ There is no significant correlation between hearing loss and acute 
complications of DM. 
¾ By maintaining strict glycemic control we can prevent occurrence 
and progression of hearing loss 
¾ Hence there is an urgent need to create awareness in children and 
their parents regarding maintenance of good glycemic control. 
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Annexure
 
82
ANNEXURE - I 
DATA COLLECTION FORM 
Sl. No                                    : 
Name     : 
Age      : 
Sex      : 
Date of registration   : 
Age at onset of diabetes  : 
Diabetic age as on registration : 
H/O hearing impairment  : 
H/O ear discharge   : 
H/O head / ear trauma   : 
Family H/O congenital deafness : 
H/O known ototoxic drug exposure : 
 
83
Associated complications 
Hypoglycemia   : 
DKA    : 
Nephropathy   : 
Retinopathy   : 
Present blood glucose level : 
Clinical assessment of hearing & 
Otoscopic examination  : 
Pure tone audiometry  : 
Level of glycemic control :  
(HBA1C level) 
  
